Lorem ipsum dolor sit amet, consectetur adipisicing elit. Reiciendis optio quam harum dignissimos hic facilis, iure, nulla quos ab quidem expedita consectetur ipsam ipsum odio sequi quis ipsa illo porro!
Fred Driscoll
Lorem ipsum dolor sit amet, consectetur adipisicing elit. Reiciendis optio quam harum dignissimos hic facilis, iure, nulla quos ab quidem expedita consectetur ipsam ipsum odio sequi quis ipsa illo porro!
Frank Morich
Lorem ipsum dolor sit amet, consectetur adipisicing elit. Reiciendis optio quam harum dignissimos hic facilis, iure, nulla quos ab quidem expedita consectetur ipsam ipsum odio sequi quis ipsa illo porro!
Pamela D. Garzone, Ph.D.
Lorem ipsum dolor sit amet, consectetur adipisicing elit. Reiciendis optio quam harum dignissimos hic facilis, iure, nulla quos ab quidem expedita consectetur ipsam ipsum odio sequi quis ipsa illo porro!
Peter Kiener
Lorem ipsum dolor sit amet, consectetur adipisicing elit. Reiciendis optio quam harum dignissimos hic facilis, iure, nulla quos ab quidem expedita consectetur ipsam ipsum odio sequi quis ipsa illo porro!
Patrick Verheyen
Lorem ipsum dolor sit amet, consectetur adipisicing elit. Reiciendis optio quam harum dignissimos hic facilis, iure, nulla quos ab quidem expedita consectetur ipsam ipsum odio sequi quis ipsa illo porro!
Frank Morich
Lorem ipsum dolor sit amet, consectetur adipisicing elit. Reiciendis optio quam harum dignissimos hic facilis, iure, nulla quos ab quidem expedita consectetur ipsam ipsum odio sequi quis ipsa illo porro!
Fred Driscoll
Lorem ipsum dolor sit amet, consectetur adipisicing elit. Reiciendis optio quam harum dignissimos hic facilis, iure, nulla quos ab quidem expedita consectetur ipsam ipsum odio sequi quis ipsa illo porro!
Colin Sandercock, M.S.E., J.D.
Colin Sandercock brings more than 30 years of experience advising life sciences companies on a broad range of legal matters, including domestic and international patent litigation, compliance, procurement, and licensing. Before joining Cue Biopharma, Sandercock was most recently a Partner at Perkins Coie since 2009. Prior to Perkins Coie, he held positions within legal firms including Proskauer Rose where he co-chaired the firm’s Life Science Practice Group; Heller Ehrman, where he co-chaired the firm’s Intellectual Property Practice Group; and Foley & Lardner, where he chaired the firm’s Chemical Practice Group. His technical experience includes life science, pharmaceutical compositions and biologics, organic and inorganic chemistries, as well as chemical and biochemical engineering. Sandercock has served as an adjunct professor of law at George Washington University Law School, lecturing on the licensing of intellectual property rights, and on the AAA Patent Advisory Committee for Patent Disputes. He received his J.D. from the Catholic University of America and received a M.S.E. in Engineering degree in Chemical and Biochemical Engineering from the University of Pennsylvania, and a B.S. in Chemistry and Mathematics from Moravian College.
Kerri-Ann Millar
Kerri-Ann Millar serves as the Chief Financial Officer. Before joining Cue Biopharma, Ms. Millar served as Corporate Controller for Flexion Therapeutics, Inc., a biopharmaceutical company focused on the development of local therapies for the treatment of patients with osteoarthritis, where she developed the finance function for the newly public company to support the commercialization of its first approved drug. Prior to Flexion Therapeutics, she served as a Finance Specialist for Curis, Inc., a biotechnology company focused on the development of oncology treatments. Prior to Curis, Ms. Millar spent over 10 years in audit and finance functions at several investment banks in the Boston area and four years at PricewaterhouseCoopers. She earned a B.S. in Accounting and Finance from Boston University and is a Certified Public Accountant.